• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Embryo Technology Might Lead to Children With Genes From Two Men

Medically reviewed by Carmen Pope, BPharm. Last updated on March 11, 2024.

By Dennis Thompson HealthDay Reporter

MONDAY, March 11, 2024 -- New technology might soon allow men in same-sex relationships to have a child genetically related to both dads, researchers say.

The technology uses skin cells from one person to alter the genetics of a donated egg, researchers reported March 8 in the journal Science Advances.

That egg can then be fertilized by a sperm cell to create a viable embryo containing the combined genetics of the skin donor and the sperm donor.

This could help same-sex couples produce their own child, as well as help women who aren’t able to produce viable eggs due to advanced age, cancer treatment or other causes.

“The goal is to produce eggs for patients who don’t have their own eggs,” said senior author Shoukhrat Mitalipov, director of the Oregon Health & Science University Center for Embryonic Cell and Gene Therapy.

This is the same technique that researchers famously used in 1996 to clone a sheep in Scotland named Dolly, researchers said.

In that case, researchers created a clone of one parent, while the OHSU researchers focused on creating embryos with genetics drawn from both parents.

The OHSU team followed a three-step process to do this in mouse experiments.

They first stripped a mouse egg of its nucleus, then transplanted the nucleus of a mouse skin cell into the mouse egg.

Next, they prompted the implanted skin cell nucleus to discard half its chromosomes, in a process similar to that which occurs in cells dividing to produce mature sperm or egg cells.

Finally, the researchers fertilize the new egg with sperm using in vitro fertilization, resulting in a healthy embryo with two sets of chromosomes equally donated by two parents.

This process could prove a simpler option to a competing technique that other labs around the world are testing, in which skin cells are fully reprogrammed to become either egg or sperm cells.

“We’re skipping that whole step of cell reprogramming,” researcher Dr. Paula Amato, a professor of obstetrics and gynecology in the OHSU School of Medicine, said in a school news release. “The advantage of our technique is that it avoids the long culture time it takes to reprogram the cell. Over several months, a lot of deleterious genetic and epigenetic changes can happen.”

However, researchers warn that it will be years before this technique could be available for humans.

“This gives us a lot of insight,” Amato said. “But there is still a lot of work that needs to be done to understand how these chromosomes pair and how they faithfully divide to actually reproduce what happens in nature.”

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.